Orexo Ab Stock Analysis
| ORXOF Stock | USD 3.23 0.00 0.00% |
Orexo AB holds a debt-to-equity ratio of 1.762. Orexo AB's financial risk is the risk to Orexo AB stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Orexo AB's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Orexo AB's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the OTC Stock is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Orexo OTC Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Orexo AB's stakeholders.
For many companies, including Orexo AB, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Orexo AB, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Orexo AB's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Orexo AB's debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Orexo AB is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Orexo AB to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Orexo AB is said to be less leveraged. If creditors hold a majority of Orexo AB's assets, the OTC Stock is said to be highly leveraged.
Orexo AB is fairly valued with Real Value of 3.19 and Hype Value of 3.23. The main objective of Orexo AB otc analysis is to determine its intrinsic value, which is an estimate of what Orexo AB is worth, separate from its market price. There are two main types of Orexo AB's stock analysis: fundamental analysis and technical analysis.
The Orexo AB otc stock is traded in the USA on OTCQX Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Orexo AB's ongoing operational relationships across important fundamental and technical indicators.
Orexo |
Orexo OTC Stock Analysis Notes
About 17.0% of the company outstanding shares are owned by corporate insiders. The book value of Orexo AB was now reported as 1.07. The company had not issued any dividends in recent years. Orexo AB , a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Orexo AB was incorporated in 1994 and is headquartered in Uppsala, Sweden. Orexo Ab is traded on OTC Exchange in the United States.The quote for Orexo AB is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Orexo AB contact Nikolaj Sorensen at 46 1 87 80 88 00 or learn more at https://www.orexo.com.Orexo AB Investment Alerts
| The company reported the revenue of 565 M. Net Loss for the year was (223.5 M) with profit before overhead, payroll, taxes, and interest of 521.7 M. | |
| Orexo AB has accumulated about 45.61 M in cash with (229 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders |
Orexo Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 58.7 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Orexo AB's market, we take the total number of its shares issued and multiply it by Orexo AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Orexo Profitablity
Orexo AB's profitability indicators refer to fundamental financial ratios that showcase Orexo AB's ability to generate income relative to its revenue or operating costs. If, let's say, Orexo AB is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Orexo AB's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Orexo AB's profitability requires more research than a typical breakdown of Orexo AB's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.28) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Technical Drivers
As of the 9th of February, Orexo AB holds the Risk Adjusted Performance of 0.0977, variance of 0.5277, and Coefficient Of Variation of 812.4. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Orexo AB, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down and interpolate data for eleven technical drivers for Orexo AB, which can be compared to its competitors. Please check Orexo AB coefficient of variation and maximum drawdown to decide if Orexo AB is priced some-what accurately, providing market reflects its current price of 3.23 per share. Given that Orexo AB has variance of 0.5277, we recommend you to check out Orexo AB's recent market performance to make sure the company can sustain itself at a future point.Orexo AB Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Orexo AB price series with the more recent values given greater weights.
Orexo AB Outstanding Bonds
Orexo AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Orexo AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Orexo bonds can be classified according to their maturity, which is the date when Orexo AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Orexo AB Predictive Daily Indicators
Orexo AB intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Orexo AB otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Orexo AB Forecast Models
Orexo AB's time-series forecasting models are one of many Orexo AB's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Orexo AB's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Orexo AB Debt to Cash Allocation
Many companies such as Orexo AB, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Orexo AB has accumulated 492.3 M in total debt with debt to equity ratio (D/E) of 1.76, which is about average as compared to similar companies. Orexo AB has a current ratio of 2.01, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Orexo AB until it has trouble settling it off, either with new capital or with free cash flow. So, Orexo AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Orexo AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Orexo to invest in growth at high rates of return. When we think about Orexo AB's use of debt, we should always consider it together with cash and equity.Orexo AB Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Orexo AB's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Orexo AB, which in turn will lower the firm's financial flexibility.Orexo AB Corporate Bonds Issued
Most Orexo bonds can be classified according to their maturity, which is the date when Orexo AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Orexo OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Orexo AB prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Orexo shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Orexo AB. By using and applying Orexo OTC Stock analysis, traders can create a robust methodology for identifying Orexo entry and exit points for their positions.
Orexo AB , a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Orexo AB was incorporated in 1994 and is headquartered in Uppsala, Sweden. Orexo Ab is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Orexo AB to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Complementary Tools for Orexo OTC Stock analysis
When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |